Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10778594rdf:typepubmed:Citationlld:pubmed
pubmed-article:10778594lifeskim:mentionsumls-concept:C0041755lld:lifeskim
pubmed-article:10778594lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:10778594lifeskim:mentionsumls-concept:C0079706lld:lifeskim
pubmed-article:10778594lifeskim:mentionsumls-concept:C0027564lld:lifeskim
pubmed-article:10778594lifeskim:mentionsumls-concept:C1546466lld:lifeskim
pubmed-article:10778594pubmed:issue7lld:pubmed
pubmed-article:10778594pubmed:dateCreated2000-6-6lld:pubmed
pubmed-article:10778594pubmed:abstractTextSince the inclusion of medical profession under Consumer Protection Act, Indian doctors are facing malpractice suits. The incidence of adverse events (AEs) is 3.4-3.7, of adverse drug events (ADEs) is 2.4-6.5 and of adverse drug reactions (ADRs) is 6.7 per 100 hospital admissions. The complications of drug-related problems (DRPs) include therapeutic failure (TF) in 23% and new medical problems (NMPs) in 10% and could lead to serious permanent disability and death in majority (42%). The incidence of negligence in serious ADEs and death is 34% and 51%, respectively. Proportion of preventable ADEs is 28-50%. Errors occur most often in prescribing (39-56%) and result in malpractice claims in 13-25% of cases. Rational prescribing, improved therapeutic knowledge through re-training and effective use of computers in prescribing could prevent errors and reduce economic consequences for patients, doctors and hospitals.lld:pubmed
pubmed-article:10778594pubmed:languageenglld:pubmed
pubmed-article:10778594pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10778594pubmed:citationSubsetIMlld:pubmed
pubmed-article:10778594pubmed:statusMEDLINElld:pubmed
pubmed-article:10778594pubmed:monthJullld:pubmed
pubmed-article:10778594pubmed:issn0004-5772lld:pubmed
pubmed-article:10778594pubmed:authorpubmed-author:BhattA DADlld:pubmed
pubmed-article:10778594pubmed:issnTypePrintlld:pubmed
pubmed-article:10778594pubmed:volume47lld:pubmed
pubmed-article:10778594pubmed:ownerNLMlld:pubmed
pubmed-article:10778594pubmed:authorsCompleteYlld:pubmed
pubmed-article:10778594pubmed:pagination715-20lld:pubmed
pubmed-article:10778594pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10778594pubmed:meshHeadingpubmed-meshheading:10778594...lld:pubmed
pubmed-article:10778594pubmed:meshHeadingpubmed-meshheading:10778594...lld:pubmed
pubmed-article:10778594pubmed:meshHeadingpubmed-meshheading:10778594...lld:pubmed
pubmed-article:10778594pubmed:meshHeadingpubmed-meshheading:10778594...lld:pubmed
pubmed-article:10778594pubmed:meshHeadingpubmed-meshheading:10778594...lld:pubmed
pubmed-article:10778594pubmed:meshHeadingpubmed-meshheading:10778594...lld:pubmed
pubmed-article:10778594pubmed:year1999lld:pubmed
pubmed-article:10778594pubmed:articleTitleDrug-related problems and adverse drug events: negligence, litigation and prevention.lld:pubmed
pubmed-article:10778594pubmed:affiliationNovartis India Limited, Khetan Bhavan, Mumbai.lld:pubmed
pubmed-article:10778594pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10778594pubmed:publicationTypeReviewlld:pubmed